Analytical performance of Bayer Immuno I(TM) estradiol and progesterone assays

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1601-1609

  Lévesque, Ann ^a,d   Letellier, Marc ^b   Dillon, Paul W ^c   Grant, Andrew ^a  

^a Ctr Res Eval in Immunodiagnostics   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c BAYER CORPORATION   (United States)

^d Immunova Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROGESTERONE;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; INFERTILITY; MENSTRUAL CYCLE; MENSTRUATION DISORDER; NORMAL HUMAN; PROGESTERONE BLOOD LEVEL;

EID: 0030827825     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1601     Document Type: Article

References (45)

1. Balos O, Lundkvist O, Wide L, Bergh T. Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle. Acta Obstet Gynecol Scand 1994;73:790-6.
2. Muse MD, Wilson EA. Monitoring ovulation: use of biochemical and biophysical parameters. Semin Reprod Endocrinol 1986;4: 301-9.
3. Fossum Gt, Vermesh M, Kletzky OA. Biochemical and biophysical indices of follicular development in spontaneous and stimulated ovulatory cycles. Obstet Gynecol 1990;75:407-11.
4. Sushanek E, Huderer K, Dobec D, Hlavati V, Simunic V, Grizelj V. Number of follicles, oocytes and embryos in human in vitro fertilization is relative to serum estradiol and progesterone patterns during different types of ovarian hyperstimulation. Eur J Obstet Gynecol Reprod Biol 1994;56:121-7.
5. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.
6. Kuhn JM, Mahoudeau JA, Billaud L, Joly J, Rieu M, Gancel A, et al. Evaluation of diagnostic criteria for Leydig cell tumours in adult men revealed by gynaecomastia. Clin Endocrinol (Oxf) 1987;26: 407-16.
7. Valensi P, Coussieu C, Pauwels A, Attali JR, Kemeny JL, Amouroux J, Sebaoun J. Feminizing Leydig cell tumor: endocrine and incubation studies. J Endocrinol Invest 1987;10:187-93.
8. Garibaldi LR, Aceto T, Weber C. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test. J Clin Endocrinol Metab 1993;76:851-6.
9. Jamin C. Surveillance biologique du traitement hormonal substitutif: se fier aux dosages plasmatiques d'estradiol ou aux produits utilisés? J Gynecol Obstet Biol Reprod 1995;24:467-74.
10. Cook NJ, Read GF. Oestradiol measurement in women on oral hormone replacement therapy: the validity of commercial test kits. Br J Biomed Sci 1995;52:97-101.
11. Cowan BD, Vandermolen DT, Long CA, Whitworth NS. Receiver-operator characteristic, efficiency analysis, and predictive value of serum progesterone concentration as a test for abnormal gestations. Am J Obstet Gynecol 1992;166:1729-34.
12. Long CA, Lincoln SR, Whitworth NS, Cowan BD. Serum progesterone predicts abnormal gestations in chlomiphene citrate conception cycles as well as in spontaneous conception cycles. Fertil Steril 1994;61:838-42.
13. Vasilev SA, Schlaerth JB, Ahn C, Sauer MV. Serum progesterone monitoring in post-molar surveillance. Gynecol Oncol 1994;54: 288-91.
14. Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization/ embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803.
15. Prien SD, Canez MS, Messer RH. Increases in progesterone after human chorionic gonadotropin administration may predict cycle outcome in patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 1994;62:1066-8.
16. Letellier M, Lévesque A, Daigle F, Grant A. Performance evaluation of automated immunoassays on the Technicon Immuno 1 system. Clin Chem 1996;42:1695-701.
17. NCCLS document EP5-T2. Evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
18. NCCLS Document C28-P. How to define, determine and utilize reference intervals in the clinical laboratory. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
19. NCCLS proposed guideline EP6-P. Evaluation of the linearity of quantitative analytical methods. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
20. ™ microparticle enzyme immunoassay [Abstract]. Clin Chem 1993;39:1164.
21. Pierard D, Van Waesberghe L, Smitz J, Van Steirteghem AC. Evaluation of five commercially available direct radio-immunoassays for the determination of 17β-estradiol in serum for the hormonal monitoring of ovarian stimulation. Ann Biol Clin 1987; 45:444-8.
22. Noel SA. Analytical characteristics and clinical applications for a chemiluminescent immunoassay (Amerlite) for serum estradiol [Abstract]. Clin Chem 1992;38:947.
23. Ooi DS, Laxdal V, Pronovost C. Two commercial automated immunoenzymometric assays for serum estradiol evaluated [Tech Brief]. Clin Chem 1994;40:147-8.
24. ® II analyzer [Abstract]. Clin Chem 1993;39:1204.
25. Jiang V, Hoke C, Ettinger B. Comparison of estradiol levels in serum by RIA and ELISA methods [Abstract]. Clin Chem 1995;41: S48.
26. Uettwiller-Geiger DL, Grand S, Gray J, O'Mara D, Malchiodi L. An evaluation of two automated nonisotopic estradiols as compared to the Pantex radio-immunoassay in an IVF setting [Abstract]. Clin Chem 1993;39:1265.
27. ® II analyzer [Abstract]. Clin Chem 1993;39:1161.
28. Pesce MA, Bodourian SH, Sheehan M, Henkel CF. An automated biotin-streptavidin procedure for progesterone evaluation. Clin Biochem 1992;25:451-5.
29. Bymes S, Branson J, Palosaari N, Eiler M, Schmidt J, Kapsner K. Development of an automated progesterone assay [Abstract]. Clin Chem 1995;41:S85.
30. Wilson H, El Shami AS, Lei J-D. An automated chemiluminescent immunoassay for progesterone on the Immulite system [Abstract]. Clin Chem 1994;40:1035
31. ® analyzer [Abstract]. Clin Chem 1990;36:1099.
32. Ross JW, Lawson NS. Analytic goals, concentration relationships, and the state of the art for clinical laboratory precision. Arch Pathol Lab Med 1995;119:495-513.
33. Fraser CG, Petersen PH. Desirable performance standards for imprecision and bias in alternate sites. Arch Pathol Lab Med 1995;119:909-13.
34. Ricos C, Arbos MA. Quality goals for hormone testing. Ann Clin Biochem 1990;27:353-8.
35. Ooi LSM, Panesar NS, Masarei JRL. Within-and between-subject variation in, and associations between, serum concentrations and urinary excretion of testosterone and estradiol in Chinese men. Clin Chim Acta 1995;236:87-92.
36. Thienpont L. Meeting report: First and Second Estradiol International Workshops. Clin Chem 1996;42:1122-4.
37. Nakajima ST, McAuliffe T, Gibson M. The 24-hour pattern of the levels of serum progesterone and immunoreactive human chorionic gonadotropin in normal early pregnancy. J Clin Endocrinol Metab 1990;71:345-53.
38. Mikkelsen AL, Borggaard B, Lebech PE. Results of serial measurement of estradiol in serum with six different methods during ovarian stimulation. Gynec Obstet Invest 1996;41:35-40.
39. Estradiol. Coat-A-Count kit insert, Diagnostic Products Corporation, Los Angeles, CA, 1994.
40. Estradiol-6. Coat-A-Count kit insert, Diagnostic Products Corporation, Los Angeles, CA, 1995.
41. Anttila L, Koskinen P, Irjala K, Kaihola H-L. Reference intervals for serum sex steroids and gonadotropins in regularly menstruating women. Acta Obstet Gynecol Scand 1991;70:475-81.
42. Lee CS, Smith NM, Kohn SN. Analytic variability and clinical significance of different assays for serum estradiol. J Reprod Med 1991;36:156-60.
43. Patricot MC, Badonnel Y, Bugugnani M-J, Collignon I, Delvigne L, Lacroix I, Mathian B. Validité des dosages immunochimiques de l'estradiol sanguin-étude réalisée en 1994. Ann Biol Clin 1995; 53:399-406.
44. Potischman N, Falk RT, Laiming VA, Siiteri PK, Hoover RN. Reproducibility of laboratory assays for steroid hormones and sex hormone-binding globulin. Cancer Res 1994;54:5363-7.
45. Progesterone. Coat-A-Count kit insert, Diagnostic Products Corporation, Los Angeles, CA, 1993.